← The Wire
PLXNYSE
Protalix BioTherapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1006281
Develops and commercializes plant cell-based protein therapeutics for rare diseases, including enzyme replacement therapies
$168M
Market cap
$2.35
Last close
+2.2%
1D
+8.8%
5D
541K
Volume
Price · last 39 sessions+10.3%
May 4L $1.90 · H $2.35Jun 29
534
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 25, 20268-KReg FD DisclosureMay 21, 202610-Q10-QMay 13, 20268-KResults of OperationsMay 13, 2026DEF 14ADEF 14AApr 30, 202610-K10-KMar 18, 20268-KResults of OperationsMar 18, 20268-KCompany UpdateMar 9, 20268-KReg FD DisclosureFeb 11, 20268-KCompany UpdateJan 30, 20268-KReg FD DisclosureJan 5, 202610-Q10-QNov 13, 20258-KResults of OperationsNov 13, 20258-KCompany UpdateNov 3, 20258-KReg FD Disclosure · Company UpdateOct 17, 20258-KMaterial AgreementAug 22, 2025424B5424B5Aug 22, 202510-Q10-QAug 14, 20258-KResults of OperationsAug 14, 20258-KCompany UpdateAug 1, 20258-KExecutive Change · Material AgreementJul 21, 20258-KShareholder VoteJun 26, 202510-Q10-QMay 9, 20258-KResults of OperationsMay 9, 2025DEF 14ADEF 14AApr 30, 20258-KExecutive ChangeApr 23, 20258-KMaterial Agreement · Company UpdateMar 17, 2025424B5424B5Mar 17, 202510-K10-KMar 17, 20258-KResults of OperationsMar 17, 20258-KSecurity-Holder Rights · Bylaw AmendmentDec 31, 20248-KReg FD DisclosureDec 23, 202410-Q10-QNov 14, 20248-KResults of OperationsNov 14, 20248-KReg FD DisclosureOct 25, 202410-Q10-QAug 14, 20248-KResults of OperationsAug 14, 20248-KShareholder VoteJun 28, 2024DEFA14ADEFA14AMay 17, 202410-Q10-QMay 10, 20248-KResults of OperationsMay 10, 2024DEF 14ADEF 14AApr 29, 202410-K10-KMar 14, 20248-KResults of OperationsMar 14, 20248-KReg FD DisclosureDec 26, 202310-Q10-QNov 6, 20238-KResults of OperationsNov 6, 20238-KExecutive ChangeSep 12, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KShareholder VoteJul 13, 20238-KShareholder VoteJun 29, 2023DEFA14ADEFA14AJun 28, 20238-KReg FD DisclosureMay 30, 2023DEF 14ADEF 14AMay 18, 20238-KResults of Operations · Company UpdateMay 18, 20238-KCompany UpdateMay 10, 20238-KCompany UpdateMay 5, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 202310-K/A10-K/AMay 1, 2023424B5424B5Feb 27, 20238-KMaterial Agreement · Company UpdateFeb 27, 202310-K10-KFeb 27, 20238-KResults of OperationsFeb 27, 20238-KCompany UpdateFeb 24, 20238-KReg FD DisclosureJan 3, 20238-KCompany UpdateDec 27, 20228-KCompany UpdateDec 21, 202210-Q10-QNov 14, 20228-KResults of Operations · Company UpdateNov 14, 20228-KMaterial AgreementSep 1, 202210-Q10-QAug 15, 20228-KResults of OperationsAug 15, 20228-KExecutive Change · Shareholder VoteJun 30, 2022DEFA14ADEFA14AJun 16, 2022SC 13GSC 13GJun 9, 20228-KReg FD DisclosureMay 26, 202210-Q10-QMay 16, 20228-KResults of OperationsMay 16, 2022
Insider Activity
In the 90 days to Dec 19, 2025: 1 insider bought $101K · 1 sold $314.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | Bashan DrorPRESIDENT AND CEO | Buy | 56,000 | $1.81 | $101K |
| Nov 18, 2025 | Bar-Shalev AmosDirector | Sell | 168 | $1.87 | $314 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance